Hengrui Medicine is a leading pharmaceutical company based in China with a focus on research, development, manufacturing, and commercialization of innovative and high-quality healthcare products. Hengrui was established in 1970 and listed in Shanghai Stock Exchange in 2000. The company ranks top 30 worldwide in pharmaceuticals industry by a market capitalization of over 50 billion USD, and has more than 25,000 employees worldwide. Hengrui not only stands out as a front-runner in cancer drugs, contrast agents, and surgical medicines, but is also a lead member of the National Anti-Tumor Medicine Technology Innovation Industry-Education-Research Alliance. Hengrui owns a National Targeted Drug Engineering Technology Research Center, and a post-doctoral research station. In May 2018, Hengrui Medicine was listed in Forbes’s top 100 world’s most innovative companies and ranked the 64th, where only 7 companies from China were on the list.
Company’s Keywords:
and
How Many Employees Does This Company Have?
4000
Which Industry Does This Company Belong To?
pharmaceuticals
What Is the Annual Income?
3718584000
What Is the Technology of All the Company’s Website?
Outlook, Microsoft-IIS, Bootstrap Framework, ASP.NET, Mobile Friendly, Nginx, F5 BIG-IP
What Year Was the Company Founded?
1970
Rate us and Write a Review
Own or work here?
Your request has been submitted successfully.
